In consistent with our study, shRNA silencing of RIPK1 in metastatic HNSCC enhances migration and low RIPK1 expression strongly correlates with metastatic phenotypes in HNSCC patients [54]. The gene discussed is RIPK1; the disease is head and neck squamous cell carcinoma.